chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Lymphadenopathy, Swelling
Clinical narrative: Swelling on left lateral chest and left flank; Soreness on left lateral chest and left flank; swollen lymph node in left anterior neck; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 at 12:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included protein powder received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, one and half day after vaccine, the patient experienced, soreness and swelling on left lateral chest and left flank. The patient did not have redness or warmth, swelling on arm or axilla; swelling and tenderness on left side had increased over the last few days; also swollen lymph node in left anterior neck. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling on left lateral chest and left flank, soreness on left lateral chest and left flank and swollen lymph node in left anterior neck was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Urticaria
Clinical narrative: broke out in hives/ bumps; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150, Expiration Date: 31Jul2021), via an unspecified route of administration, administered in the left arm on 19Apr2021 (at the age of 32 years old) as dose 1, single for COVID-19 immunisation. The patient has no medical history. The patient's concomitant medications were not reported. On 19Apr2021, the patient broke out in hives and went to the emergency room. He also reported that he took the vaccine on 19Apr2021 and once he went to home he was taking out with bumps, the real bumps and he went to the emergency room. The patient underwent lab tests and procedures which included blood work: unknown results on an unspecified date in Apr2021. The patient was given medications for bumps and the hives which included prednisone 20mg and IC famotidine 20mg (as reported). The patient was improving (recovering) from the event.  No follow-up attempts are possible. No further information is expected
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash
Clinical narrative: Rash covering face and upper chest; including headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 14:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, post-concussion syndrome and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 09Apr2021, the patient experienced rash covering face, upper chest including headaches. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash covering face and upper chest including headaches were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Pyrexia, Vomiting
Clinical narrative: Fatigue, vomiting, fever, chills, for 1 day, the following day extremely swollen lymph nodes under left arm
Age: 35.0
Sex: F
Vaccine: ADEN_4_7
Symptoms: Pyrexia
Clinical narrative: Pt. had fever 102.6
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Feeling abnormal, Insomnia, Palpitations, Suicidal ideation
Clinical narrative: Racing heartbeat and heart palpitations; insomnia; anxiety; brain fog; suicidal ideation
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Lymph node pain, Lymphadenopathy, Pain, Swelling
Clinical narrative: Right axillary area swollen and very tender to touch or movement. Area feels inflamed. Tylenol and Aleve used as directed. Ice packs placed. Pain and swelling still present 24 hours later but slightly less discomfort.
Age: 23.0
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: Sore arm and swelling 4 hours after vaccination. Fever, chills, nausea, body aches, head ache 12 hours after vaccination which lasted through the entire night into the next day
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Swelling
Clinical narrative: Sore arm and swelling 4 hours after vaccination. Fever, chills, nausea, body aches, head ache 12 hours after vaccination which lasted through the entire night into the next day
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dizziness, Fatigue, Feeling abnormal, Hyperthyroidism
Clinical narrative: I developed subacute thyroiditis 5 days after vaccination. I had pain and inflammation in my thyroid, neck and mouth. My THS , T3 and T4 indicated hyperthyroidism and subsequent hypothyroidism. I continue to take medication for hypothyroidism at 7 months and was feeling extreme fatigue, brain fog and lightheaded/ill until abt 8 weeks ago.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypothyroidism, Inflammation, Neck pain, Oral pain, Thyroid pain
Clinical narrative: I developed subacute thyroiditis 5 days after vaccination. I had pain and inflammation in my thyroid, neck and mouth. My THS , T3 and T4 indicated hyperthyroidism and subsequent hypothyroidism. I continue to take medication for hypothyroidism at 7 months and was feeling extreme fatigue, brain fog and lightheaded/ill until abt 8 weeks ago.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thyroiditis subacute
Clinical narrative: I developed subacute thyroiditis 5 days after vaccination. I had pain and inflammation in my thyroid, neck and mouth. My THS , T3 and T4 indicated hyperthyroidism and subsequent hypothyroidism. I continue to take medication for hypothyroidism at 7 months and was feeling extreme fatigue, brain fog and lightheaded/ill until abt 8 weeks ago.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 20Apr2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and esomeprazole sodium (NEXIUM); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously took promethazine (PHENERGAN) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8721) via an unspecified route of administration in the right arm on 30Mar2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient experienced headache, fatigue, nausea and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fatigue, nausea and diarrhea were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: Joint bone pain entire body still have it; hands, wrists, ankles and feet had shooting burning pains; can't function, type, cook, or anything; hands, wrists, ankles and feet had shooting burning pains; This is a spontaneous report from a contactable consumer (patient) received via the regulatory authority. A non-pregnant 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 17Mar2021 05:15 (Lot Number: Eng204) (at the age of 54 years old) as dose 1, single for COVID-19 immunisation (also reported as dose number 2 on 17Mar2021 at 17:15 Lot Number: En6204; for confirmation). The vaccine was administered in a Pharmacy or Drug Store. The patient's medical history included asthma, inflammatory bowel disease, and known allergies: penicillin and latex. Concomitant medications included ipratropium bromide;salbutamol sulfate (COMBIVENT), montelukast, and "ALBATROS" for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 16Apr2021 02:00, the patient experienced "Joint bone pain entire body still have it". The patient can't function, type, cook, or anything. The hands, wrists, ankles, and feet had shooting burning pains. The events resulted in a Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient received prednisone as a treatment. The patient has not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival swelling, Palatal swelling, Stomatitis
Clinical narrative: The roof of my mouth and my gums became very inflamed/swollen; The roof of my mouth and my gums became very inflamed/swollen; The roof of my mouth and my gums became very inflamed/swollen; This is a spontaneous report from a contactable consumer (patient).   A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 12:00 (Batch/Lot Number: EW0164) as single dose for covid-19 immunisation. Medical history included rheumatoid arthritis, penicillin allergy. The patient had received the first dose of the same vaccine from Lot number=ER8732 on 30Mar2021 01:00 PM at the age of 61 years old, at the left arm. The patient experienced the roof of my mouth and my gums became very inflamed/swollen on 19Apr2021 with outcome of recovering. The patient received treatment for the events, IV Steroid, and a prescription for Oral steroids. The patient was not pregnant. No covid prior vaccination, the patient was not tested post vaccination. The events were assessed as serious.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Diarrhoea, Fatigue, Hyperhidrosis
Clinical narrative: Abdominal pain; Vomiting; Diarrhea; Sweating; Chills; Migraine; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any medication within two weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 18:45 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 08:15, the patient experienced abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm and fatigue . No therapeutic measures were taken as a result of events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event Abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm, fatigue was resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain in extremity, Vomiting
Clinical narrative: Abdominal pain; Vomiting; Diarrhea; Sweating; Chills; Migraine; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any medication within two weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 18:45 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 08:15, the patient experienced abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm and fatigue . No therapeutic measures were taken as a result of events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event Abdominal pain, vomiting, diarrhea, sweating, chills, migraine, sore arm, fatigue was resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Condition aggravated, Extrasystoles, Heart rate irregular, Hypotonia
Clinical narrative: I have afib. After second dose, my Afib gradually worsened.; I have afib. After second dose, my Afib gradually worsened.; At 3 weeks out it peaked with very irregular heartbeat, flopping, skipping beats; flopping; skipping beats; This is a spontaneous report from a contactable consumer (Patient) or other non HCP.   A 70-years-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9809, Expiry date was not reported), via an unspecified route of administration on 09Mar2021 (at the age of 70-years-old) in Arm Right as dose 2, single for COVID-19 immunization. The Patient Medical history included atrial fibrillation from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing known allergies Sulphur, shellfish. Concomitant medication(s) included propafenon; retinol palmitate, vitamin d nos (VIT A+D); colecalciferol, menadione (VITAMIN K+D); calcium; magnesium; acetylsalicylic acid (ASPIR) all taken for an unspecified indication, start and stop date were not reported. The patient previously took sulphur for drug hypersensitivity. Previously patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EM9810 and Expiry date was not reported), via an unspecified route of administration on 16Feb2021, 06:45 PM in Arm Right as dose 1, single for COVID-19 immunization. The Patient was not pregnant at the time of vaccination. The patient was not received other vaccines in four weeks. The Patient was not diagnosed with COVID prior vaccination and Patient was not tested COVID post vaccination. On 12Mar2021, 13:15, the patient experienced she have afib. after second dose, her afib gradually worsened. At 3 weeks out it peaked with very irregular heartbeat, flopping, skipping beats. Totally cut out caffeine and white sugar. 5 days later it finally got back to normal. Thinking it might be related to the vaccine. The Patient visited Physician office. The Patient visited emergency room for event Flopping. The Patient had not received the treatment for the events. The outcome for all the events was recovered with sequel on unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pain, Pyrexia
Clinical narrative: When I woke up in the morning, pain was gone, but entire body is weak; About 8 hours after receiving the vaccine, i started getting feverish and had a headache.; About 8 hours after receiving the vaccine, i started getting feverish and had a headache.; Slowly started having severe pain in both legs from my waist down to my toes for about 6 hours; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 21Apr2021 at 08:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 at 08:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 16:00, about 8 hours after receiving the vaccine, the patient started getting feverish and had a headache. Slowly she started having severe pain in both legs from her waist down to her toes for about 6 hours. When the patient woke up in the morning, pain was gone, but entire body was weak and still had a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event slowly started having severe pain in both legs from waist down to toes for about 6 hours was resolved the next morning on 22Apr2021. The clinical outcome of the events about 8 hours after receiving the vaccine, started getting feverish and of entire body was weak was resolving, while that of headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vertigo
Clinical narrative: Am experiencing heavy vertigo/dizziness 6 days later. has been happening for over 24 hours.; Am experiencing heavy vertigo/dizziness 6 days later. has been happening for over 24 hours.; Normal arm soreness the day after. severe pain in same arm 5 days later, for roughly 6 hours; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 15Apr2021 at 17:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included bupropion (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), trazodone hydrochloride (DEPRAX) and duloxetine hydrochloride (CYMBALTA); all for unknown indication on unknown date and unknown if ongoing. The patient previously took buspirone (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced normal arm soreness the day after on 16Apr2021, and severe pain in same arm 5 days later, for roughly 6 hours. The patient also experienced heavy vertigo and dizziness 6 days later on 21Apr2021 and it had been happening for over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events normal arm soreness the day after, severe pain in same arm 5 days later, for roughly 6 hours; experienced heavy vertigo and dizziness 6 days later and it had been happening for over 24 hours was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, SARS-CoV-2 test, Skin mass
Clinical narrative: Red rash formed on neck; Patch on elbow of right arm, rash is all over neck, behind one ear, multiple patches on right arm; A few small bumps on left arm; Arms itch; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified medication for birth control from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, 2 days after the vaccination, the patient experienced red rash formed on her neck. Next morning, another patch on elbow of her right arm. Now it was been a week and the rash were all over her neck, behind her one ear, multiple patches on her right arm. And a few small bumps on left arm. Arms itch. Neck not as much. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On 14Apr2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the events red rash formed on neck, patch on elbow of right arm, rash was all over neck, behind one ear, multiple patches on right arm, a few small bumps on left arm and arms itch was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Body temperature increased, Fatigue, Headache
Clinical narrative: Within 36hrs, experienced extreme abdominal pains on the left side of the abdomen; Within 12hrs of dose, experienced flu-like symptoms; Elevated body temperature (no fever); Aches; Headache; Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 02:00, within 12 hours of dose, the patient experienced flu-like symptoms with elevated body temperature (no fever), aches, headache, nausea, and fatigue. On 17Apr2021 at 01:00, within 36 hours, the patient experienced extreme abdominal pains on the left side of his abdomen, which passed within 12 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. On 16Apr2021 at 02:00, the patient underwent body temperature test and the result was increased. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events within 12 hours of dose, experienced flu-like symptoms, elevated body temperature (no fever), aches, headache, nausea and fatigue was resolved on an unknown date in Apr2021 while the event within 36 hours, experienced extreme abdominal pains on the left side of the abdomen was resolved on 17Apr2021 at 13:00.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, Pain
Clinical narrative: Within 36hrs, experienced extreme abdominal pains on the left side of the abdomen; Within 12hrs of dose, experienced flu-like symptoms; Elevated body temperature (no fever); Aches; Headache; Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 02:00, within 12 hours of dose, the patient experienced flu-like symptoms with elevated body temperature (no fever), aches, headache, nausea, and fatigue. On 17Apr2021 at 01:00, within 36 hours, the patient experienced extreme abdominal pains on the left side of his abdomen, which passed within 12 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. On 16Apr2021 at 02:00, the patient underwent body temperature test and the result was increased. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events within 12 hours of dose, experienced flu-like symptoms, elevated body temperature (no fever), aches, headache, nausea and fatigue was resolved on an unknown date in Apr2021 while the event within 36 hours, experienced extreme abdominal pains on the left side of the abdomen was resolved on 17Apr2021 at 13:00.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Fatigue, Nausea, Pain
Clinical narrative: Severe whole arm pain (injection arm couldn't use); Severe dizziness; Severe tiredness; Bad metallic taste in mouth; Moderate body pain; Mild nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0138) via an unspecified route of administration in the left arm on 16Apr2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, upper respiratory allergies and known allergy to soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metronidazole (MANUFACTURER UNKNOWN), glycopyrronium bromide, formoterol fumarate, budesonide (BREZTRI AEROSPHERE) and levocetirizine (MANUFACTURER UNKNOWN); all taken for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced drug allergy. On 16Apr2021 at 13:00, 2.5 hours after injection, the patient experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea which lasted for 48 hours. After 48 hours the symptoms started to wane and resolved after 72 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events.  The clinical outcome of the events experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea was recovered on 19Apr2021 at 13:00.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Severe whole arm pain (injection arm couldn't use); Severe dizziness; Severe tiredness; Bad metallic taste in mouth; Moderate body pain; Mild nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0138) via an unspecified route of administration in the left arm on 16Apr2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, upper respiratory allergies and known allergy to soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metronidazole (MANUFACTURER UNKNOWN), glycopyrronium bromide, formoterol fumarate, budesonide (BREZTRI AEROSPHERE) and levocetirizine (MANUFACTURER UNKNOWN); all taken for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced drug allergy. On 16Apr2021 at 13:00, 2.5 hours after injection, the patient experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea which lasted for 48 hours. After 48 hours the symptoms started to wane and resolved after 72 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events.  The clinical outcome of the events experienced severe whole arm pain (injection arm couldnt use), severe dizziness, severe tiredness, bad metallic taste in mouth, moderate body pain and mild nausea was recovered on 19Apr2021 at 13:00.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Decreased appetite, Diarrhoea, Dizziness
Clinical narrative: Nausea; Diarrhea; Headache; Dizziness; No appetite; Balance issues; Lungs hurt; Muscle aching; Chills; Dose 1: 27Mar2021, Dose 2: 04Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and undifferentiated connective tissue disease (utcd). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. The patient previously received nitrofurantoin (MACROBID) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 10:30, the patient experienced nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Myalgia, Nausea, Pulmonary pain
Clinical narrative: Nausea; Diarrhea; Headache; Dizziness; No appetite; Balance issues; Lungs hurt; Muscle aching; Chills; Dose 1: 27Mar2021, Dose 2: 04Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and undifferentiated connective tissue disease (utcd). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. The patient previously received nitrofurantoin (MACROBID) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 10:30, the patient experienced nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling, Tenderness
Clinical narrative: Sensitive to the touch at the time I am writing this (60 hours after vaccine).; 36 hours after the shot it was visibly swollen and painful; Left armpit started swelling 24 hours after shot; 36 hours after the shot it was visibly swollen and painful. No visible lymph nodes, just general swelling. Swelling went down after ~48 hours but still somewhat painful and sensitive to the touch; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 16Apr2021 at 17:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 at 17:00, 24 hours after shot the patient's left armpit started swelling; 36 hours after the shot on 18Mar2021 at 05:00, it was visibly swollen and painful. No visible lymph nodes, just general swelling. Swelling went down after 48 hours but still somewhat painful. Swelling was sensitive to the touch on 20Apr2021 at 08:47 the time, the patient was writing this report (also reported as 60 hours after vaccine). The events were reported because the patient read that swollen gland were only found in 0.3 percentage of Pfizer vaccine patients, but it may be more common. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, left armpit started swelling 24 hours after shot; 36 hours after the shot it was visibly swollen and painful, swelling went down after 48 hours but still somewhat painful and sensitive to the touch were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding, Menstruation irregular
Clinical narrative: Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; Heavy, irregular period in timeframe after vaccine spotting bleeding for about a month, then heavier than usual flow; More painful than usual cramps at expected period date.; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 28-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) for unknown indication on unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 the patient experienced heavy, irregular period in timeframe after vaccine. There was spotting bleeding for about a month, then heavier than usual flow and more painful than usual cramps at expected period date. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events experienced heavy, irregular period in timeframe after vaccine; spotting bleeding for about a month, then heavier than usual flow and more painful than usual cramps at expected period date was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Diarrhoea, Muscular weakness
Clinical narrative: Terrible diarrhea; Weakness in legs where "I" could not stand up; Chills; Broke out in a cold sweat; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 19Apr2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure, high cholesterol, depression, anxiety, hypothyroidism, penicillin allergy and allergy to all fruits and fruit pectin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included dulaglutide (TRULICITY) and lisinopril (MANUFACTURER UNKNOWN); both for unknown indication from an unknown start date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 20:45 (also reported as 21:00), approximately 3 hours after the vaccination, the patient experienced terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and also had chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and chills was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Heart rate increased, Hypopnoea
Clinical narrative: After dinner time, about 6pm signs started showing: shallow breathing; Fast heartbeat; Weakness; Strong pain in arm; Strong pain in wrist; Strong pain in neck; Face and neck felt puffy; Feeling unwell; Tired; Joint pain; Awoke a few times at night with strong nausea; This is a spontaneous report received from a contactable consumer, the patient. A 40-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included herpes (herpes virus infection) for which patient took valtrex occasionally. The patient had no known allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included valaciclovir hydrochloride (VALTREX) for herpes from unknown date and unknown if ongoing. On 21Apr2021 at 18:00, after dinner time, the patient experienced shallow breathing, fast heartbeat, weakness, strong pain in arm, wrist and neck, face and neck felt puffy, feeling unwell, tired, joint pain and awoke a few times at night with strong nausea. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of events strong pain in arm, wrist and neck, face and neck and joint pain which included treatment with paracetamol (TYLENOL) which helped with the pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shallow breathing, fast heartbeat, weakness, strong pain in arm, wrist and neck, face and neck felt puffy, feeling unwell, tired, joint pain and awoke a few times at night with strong nausea was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.